Rong-Sen Meng Selected Research

Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)

1/2011

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rong-Sen Meng Research Topics

Disease

2	Cardiomegaly (Heart Hypertrophy) 01/2011 - 10/2009
2	Hypertrophy 01/2011 - 10/2009
1	Acute Kidney Injury (Acute Renal Failure) 02/2023
1	Infections 02/2023
1	Urinary Tract Infections (Urinary Tract Infection) 02/2023
1	Bone Fractures (Bone Fracture) 02/2023
1	Heart Failure 01/2023

Drug/Important Bio-Agent (IBA)

2	dapagliflozinIBA 02/2023 - 01/2023
2	AMP-Activated Protein KinasesIBA 01/2011 - 10/2009
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	empagliflozinIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2011
1	Adenosine Monophosphate (AMP)IBA 10/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2009
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2009
1	4-aminoimidazoleIBA 10/2009
1	Atrial Natriuretic Factor (ANF)IBA 10/2009
1	Protein Kinases (Protein Kinase)IBA 10/2009
1	AICA ribonucleotide (ZMP)IBA 10/2009
1	Small Interfering RNA (siRNA)IBA 10/2009
1	PPAR alphaIBA 10/2009

Therapy/Procedure

1	Surgical Amputation (Amputations) 02/2023